{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:05:53Z","timestamp":1762520753123,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007899","name":"University of Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007899","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.conctc.2021.100701","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T17:20:40Z","timestamp":1610644840000},"page":"100701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Protocol for a feasibility and early efficacy study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2)"],"prefix":"10.1016","volume":"21","author":[{"given":"A.M.","family":"Algotar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M.","family":"Babiker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.T.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.H.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-H.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.G.","family":"Marrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.S.","family":"Courneya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Ligibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.conctc.2021.100701_bib1","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA A Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.conctc.2021.100701_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4111\/kju.2015.56.1.12","article-title":"Metabolic effects of androgen deprivation therapy","volume":"56","author":"Choi","year":"2015","journal-title":"Korean J Urol"},{"issue":"1","key":"10.1016\/j.conctc.2021.100701_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/iju.13473","article-title":"Metabolic changes in patients with prostate cancer during androgen deprivation therapy","volume":"25","author":"Mitsuzuka","year":"2018","journal-title":"Int. J. Urol."},{"issue":"6","key":"10.1016\/j.conctc.2021.100701_bib4","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.juro.2015.03.070","article-title":"Uncovering the metabolic complications of androgen deprivation therapy in patients with prostate cancer--where do we take it next?","volume":"193","author":"Pinthus","year":"2015","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.conctc.2021.100701_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.eururo.2014.11.039","article-title":"Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis","volume":"68","author":"Bosco","year":"2015","journal-title":"Eur. Urol."},{"issue":"17","key":"10.1016\/j.conctc.2021.100701_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/jnci\/djs299","article-title":"Temporal trends in cause of death among Swedish and US men with prostate cancer","volume":"104","author":"Epstein","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.conctc.2021.100701_bib7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3109\/0284186X.2012.682627","article-title":"Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer","volume":"51","author":"Dieperink","year":"2012","journal-title":"Acta Oncol."},{"issue":"9","key":"10.1016\/j.conctc.2021.100701_bib8","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(17)30426-6","article-title":"Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial","volume":"18","author":"Duchesne","year":"2017","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.conctc.2021.100701_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/aja.2011.108","article-title":"Quality of life issues in men undergoing androgen deprivation therapy: a review","volume":"14","author":"Casey","year":"2012","journal-title":"Asian J. Androl."},{"issue":"7","key":"10.1016\/j.conctc.2021.100701_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1200\/JCO.2015.61.6375","article-title":"Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, exercise, and nutrition (LEAN) study","volume":"34","author":"Harrigan","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.conctc.2021.100701_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.conctc.2021.100701_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41391-019-0126-5","article-title":"A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial","author":"Freedland","year":"2019","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"27","key":"10.1016\/j.conctc.2021.100701_bib13","article-title":"Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: an update meta-analysis","volume":"96","author":"Yunfeng","year":"2017","journal-title":"Medicine (Baltim.)"},{"issue":"2","key":"10.1016\/j.conctc.2021.100701_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/ERC-15-0456","article-title":"Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials","volume":"23","author":"Teleni","year":"2016","journal-title":"Endocr. Relat. Canc."},{"issue":"1","key":"10.1016\/j.conctc.2021.100701_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10880-012-9308-1","article-title":"Association of stress management skills and perceived stress with physical and emotional well-being among advanced prostrate cancer survivors following androgen deprivation treatment","volume":"20","author":"Penedo","year":"2013","journal-title":"J. Clin. Psychol. Med. Settings"},{"issue":"4","key":"10.1016\/j.conctc.2021.100701_bib16","first-page":"549","article-title":"Sleep and daily functioning during androgen deprivation therapy for prostate cancer","volume":"20","author":"Hanisch","year":"2011","journal-title":"Eur. J. Canc. Care"},{"issue":"2","key":"10.1016\/j.conctc.2021.100701_bib17","doi-asserted-by":"crossref","DOI":"10.2196\/12579","article-title":"Comprehensive lifestyle improvement program for prostate cancer (CLIPP): protocol for a feasibility and exploratory efficacy study in men on androgen deprivation therapy","volume":"8","author":"Algotar","year":"2019","journal-title":"JMIR Res Protoc"},{"issue":"9702","key":"10.1016\/j.conctc.2021.100701_bib18","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","author":"Diabetes Prevention Program Research","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.conctc.2021.100701_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2017-000422","article-title":"Engagement and outcomes in a digital diabetes prevention program: 3-year update","volume":"5","author":"Sepah","year":"2017","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865421000041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865421000041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:01:35Z","timestamp":1762520495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865421000041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":19,"alternative-id":["S2451865421000041"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2021.100701","relation":{},"ISSN":["2451-8654"],"issn-type":[{"type":"print","value":"2451-8654"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol for a feasibility and early efficacy study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2)","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2021.100701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100701"}}